High sensitivity
molecular diagnostics
ZiP Diagnostics undertakes domestic manufacture of cutting-edge molecular diagnostic test systems for infectious diseases for laboratory and point-of-care applications.
ZiP systems provide the advantage of diagnostics that can be quickly deployed to deliver fast, accurate, low-cost and simple work flow testing.
ZiP is developing test systems for chlamydia and gonorrhoea, in low to middle-income countries and a SARS-CoV-2 (COVID-19) diagnostic for Australian domestic applications.The ZiP-CoVx diagnostic test is intended for use in a broad range of settings, including: government, health, travel, defence, education, mining, industry, and sport.